medigraphic.com
ISSN 2225-4676 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2021; 11 (2)

Neoplasms of the central and intracranial nervous system

Velásquez-Pérez L, Romano-Guzmán PB, Rembao-Bojórquez JD, Salinas-Lara C, Tena-Suck ML

Language: Spanish
References: 26
Page:
PDF size: 388.23 Kb.


ABSTRACT

Objective: To describe the behavior of neoplasms presentation of the central and intracranial nervous system, in a Mexican health institution specialized in neurosurgical sufferings.
Methods: A descriptive study was carried out in a sample was made up of 7768 patients with histopathological diagnosis neoplasms of central and intracranial nervous system. They were assisted at the National Institute of Neurology and Neurosurgery, from Mexico City, from 2006 to 2017. The variables studied were the incidence and year of presentation of tumors, type of tumor, sex and age of presentation. Depending on the morphological and immunohistochemical diagnosis of tumors, these were categorized in accordance with the classification of tumors by 2007 WHO Central Nervous System. Simple frequencies were obtained; the incidence reason was calculated for each category. The trend over time was analyzed with the Pearson correlation coefficient; a p≤ 0.05 was considered statistically significant.
Results: The general incident rate was 70.2 x 100 biopsies-year. The most frequent tumors were neurepithelial tissue (30.8%) and meninges (27.6%), with predominance in women (p <0.05). An increase in embryonic tumors (p <0.005) was evidenced.
Conclusions: A tendency was not found in the increase of tumors of the central nervous system over the period studied. However, the incidence of this type of neoplasms is high. They cause high mortality and disability in those who have them.


REFERENCES

  1. Leece R, Xu J, Ostrom QT, Chen Y, Kruchko C, Barnholtz-Sloan JS. Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007. Neuro Oncol. 2017 [citado: 28/08/2020];19(11):1553-64. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28482030

  2. Sinning M. Clasificación de los Tumores Cerebrales. Rev Med Clin Condes. 2017 [citado: 28/08/2020];28:339-42. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-clasificacion-de-los-tumores-cerebrales-S0716864017300597

  3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO Classification of Tumors of the Central Nervous System. Acta Neuropathol. 2007 [citado: 28/08/2020];114:97-109. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17618441/

  4. Kleihues O, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO Classification of Tumors of Nervous System. J Neuropathol Exp Neurol. 2002 [citado: 28/08/2020];61(3):215-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11895036/

  5. Louis DN, Perry A, Reinferberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 [citado: 28/08/2020];131:803-20. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27157931

  6. Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruvhko, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017 [citado: 28/08/2020];19(5):v1-88. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29117289/

  7. Jung KW, Ha J, Lee SH, Won YJ, Yoo H. An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea. Brain Tumor Res Treat. 2013 [citado: 28/08/2020];1(1):16-23. Disponible en: https://doi.org/10.14791/btrt.2013.1.1.16

  8. Anaya Delgadillo G, de Juambelz Cisneros PP, Fernández Alvarado B, Pazos Gómez F, Velasco Torre A, Revuelta Gutiérrez R. Prevalencia de tumores del sistema nervioso central y su identificación histológica en pacientes operados: 20 años de experiencia. Cir Cir. 2016 [citado: 28/08/2020];84:447-53. Disponible en: https://www.elsevier.es/es-revista-cirugia-cirujanos-139-articulo-prevalencia-tumores-del-sistema-nervioso-S0009741116000116

  9. Nibhoria S, Tiwana KK, Phutela R, Bajaj A, Chhabra S, Bansal S. Histopathological Spectrum of Central Nervous System Tumors: A Single Centre Study of 100 Cases. Int J Sci Stud. 2015 [citado: 28/08/2020];3(6):130-4. Disponible en: https://www.researchgate.net/publication/324896263_Histopathological_Spectrum_of_Central_Nervous_System_Tumors_A_Single_Centre_Study_of_100_Cases

  10. Páez Rodríguez AM, Burbano Erazo NM, Merchancano Delgado CL, Erazo Bravo NJ, Muñoz Bolaños AB. Caracterización de los tumores cerebrales en un Hospital Universitario de Pereira, Colombia : un estudio retrospectivo. Rev Méd Risaralda. 2013 [citado: 28/08/2020];19:120-5. Disponible en: http://revistas.utp.edu.co/index.php/revistamedica/article/viewFile/8023/5399

  11. Pouchieu C, Gruber A, Berteaud E, Menégon P, Monteil P, Huchet A, et al. Increasing incidence of central nervous system (CNS) tumors (2000-2012): findings from a population based registry in Gironde (France). BMC Cancer. 2018 [citado: 28/08/2020];18:653-65. Disponible en: https://www.researchgate.net/publication/325758133_Increasing_incidence_of_central_nervous_system_CNS_tumors_2000-2012_Findings_from_a_population_based_registry_in_Gironde_France

  12. Caldarella A, Crocetti E. Is the incidence of brain tumors really increasing? A population-based analysis from a cancer registry. J Neurooncol. 2011 [citado: 28/08/2020];104:589-94. Disponible en: https://link.springer.com/article/10.1007/s11060-011-0533-5

  13. Gigineishvili D, Gigineishvili T, Tsiskaridze A, Shakarishvili R. Incidence rates of the Primary brain tumours in Georgia- a population-based study. BMC Neurol. 2014 [citado: 28/08/2020];14:29-36. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927585

  14. Dubrow R, Darefsky AS. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer. 2011 [citado: 28/08/2020];29:325-34. Disponible en: https://www.researchgate.net/publication/51532695_Demographic_variation_in_incidence

  15. Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, et al. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Eur J Endocrinol. 2015 [citado: 28/08/2020];173:655-64. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26423473

  16. Tjörnstrand A, Gunnarson K, Evert M, Holmberg E, Ragnarsson O, Rosén T, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol. 2014 [citado: 28/08/2020];171:519-26. Disponible en: https://europepmc.org/article/med/25084775

  17. Blitshteyn S, Crook JE, Jaeckle KA. Is there an Association Between Meningioma and Hormone Replacement Therapy? J Clin Oncol. 2008 [citado: 28/08/2020];26(2):279-82. Disponible en: https://ascopubs.org/doi/pdf/10.1200/JCO.2007.14.2133

  18. Sun T, Plutynski A, Ward S, Rubin JB. An integrative view on sex differences in brain tumors. Cell Moll Life Sci. 2015 [citado: 28/08/2020];72(17):3323-42. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531141

  19. Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychiting M, et al. Risk of Brain Tumors Associated with Exposure to Exogenous Female Sex Hormones. Am J Epidemiol. 2006 [citado: 28/08/2020];164(7):629-36. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/16835295

  20. Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017 [citado: 28/08/2020];19(2):270-80. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27571887/

  21. Piñeros M, Sierra MS, Izarzugaza MI, Forman D. Descriptive epidemiology of brain and central nervous system cancers in Central and South America. Cancer Epidemiol. 2016 [citado: 28/08/2020];44(Suppl 1):S141-149. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27678316/

  22. Fuentes-Raspall R, Solans M, Roca-Barceló A, Vilardell L, Puigdemont M, Del Barco S, et al. Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013). Cancer Epidemiol. 2017 [citado: 28/08/2020];50(PartA):1-8. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1877782117301042?via%3Dihub

  23. García RS, Salinas LC, Tena SM, Gómez LM, Rembao BD. Tumores germinales del sistema nervioso central. Estudio clínico patológico e inmunohistoquímico de 24 casos. Patol Rev Latinoam. 2008 [citado: 28/08/2020];46(3):228-36. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=19808

  24. Macías-Martínez CG, Kuri-Morales P. Resultados del registro histopatológico de neoplasias en México 1995. Gac Med. Mex. 1998 [citado: 28/08/2020];134(3):337-42. Disponible en: http://www.anmm.org.mx/bgmm/1864_2007/1998-134-3-337-342.pdf

  25. Meneses-García A, Ruíz-Godoy LM, Beltrán-Ortega A, Sánchez Cervantes F, Tapia-Conyer R, Mohar A. Principales neoplasias malignas en México y su distribución geográfica (1993-2002). Rev Invest Clin. 2012 [citado: 28/08/2020];64(4):322-29. Disponible en: https://www.medigraphic.com/pdfs/revinvcli/nn-2012/nn124b.pdf

  26. Adaco-Sarvide F, Pérez-Pérez P, Cervantes-Sánchez G, Torrecillas-Torres L, Erazo-Valle-Solís AA, Cabrera-Galeana P, et al. Mortalidad por cáncer en México: Actualización 2015. GAMO. 2018 [citado: 28/08/2020];17(1):28-34. Disponible en: https://www.researchgate.net/publication/324522811_Mortalidad_por_Cancer_en_Mexico




2020     |     www.medigraphic.com